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Herpesviruses, including human cytomegalovirus
(HCMV), encodemultiple microRNAs (miRNA) whose
targets are just being uncovered. Moreover, miRNA
function during the virus life cycle is relatively
unknown. We find that HCMV miRs UL112-1,
US5-1, and US5-2 target multiple components of
the host secretory pathway, including VAMP3,
RAB5C, RAB11A, SNAP23, and CDC42. A HCMV
miR UL112-1, US5-1, and US5-2 triple mutant
displayed aberrant morphogenesis of the virion as-
sembly compartment (VAC), increased secretion of
noninfectious particles, and increased IL-6 release
from infected cells. Ectopic expression of miRs
UL112-1, US5-1, and US5-2 or siRNAs directed
against RAB5C, RAB11A, SNAP23, and CDC42
caused the loss of Golgi stacks with reorganization
into structures that resemble the VAC and a decrease
in cytokine release. These observations indicate that
multiple HCMV miRNAs coordinately regulate reor-
ganization of the secretory pathway to control cyto-
kine secretion and facilitate formation of the VAC
for efficient infectious virus production.
INTRODUCTION
Human cytomegalovirus (HCMV) is a b-herpesvirus that encodes
multiple microRNAs (miRNAs) (Grey et al., 2005; Pfeffer et al.,
2004; Stark et al., 2012). miRNAs are small noncoding RNAs
(19–22 nucleotides) that posttranscriptionally regulate gene
expression. In general, miRNAs target the 30 untranslated region
(30 UTR) of mRNAs through the RNA-induced silencing complex
(RISC) that leads to translational repression and degradation of
the targeted mRNA (Lim et al., 2003). The miRNA targets of
herpesvirus miRNAs are slowly emerging and include both viral
transcriptional activators and cellular genes involved in immune
evasion, signaling, and apoptosis (Abend et al., 2010; Grey et al.,
2007; Lei et al., 2010; Stern-Ginossar et al., 2007; Umbach et al.,Cell Ho2008; Samols et al., 2007; Ziegelbauer et al., 2009; Kim et al.,
2012). HCMVmiRNA targets include viral genes such as the virus
major immediate-early gene product IE72 and US7, as well
as cellular genes involved in immune defense such as the cellular
major histocompatibility complex class I-related chain B (MICB),
a stress-induced ligand of the natural killer (NK) cell activating
receptor NKG2D, and RANTES (Grey et al., 2007; Stern-Ginos-
sar et al., 2007; Tirabassi et al., 2011; Kim et al., 2012).
miRNAs may converge on related pathways and even exhibit
redundant roles in targeting genes such as cellular miR-1 and
miR-133, regulating skeletal muscle proliferation and differentia-
tion (Chen et al., 2006). The first indication that viral miRNAs
target functionally related genes in a cellular pathway was the
observation that the targets of HCMV miR-US25-1 regulate
multiple genes involved in cell-cycle regulation, tumor progres-
sion, and chromatin remodeling (Grey et al., 2010). Additional
evidence derives from the identification of the Kaposi’s sar-
coma-associated herpesvirus (KSHV) and Epstein-Barr virus
(EBV) miRNA cellular targetomes using photoactivatable-ribonu-
cleoside enhanced crosslinking (PAR-CLIP) with RISC immuno-
precipitation biochemical analyses. In these studies, KSHV
and EBV miRNAs in latently infected transformed cells were
observed to target multiple genes involved in transcriptional
regulation, signal transduction, innate immunity, vesicular traf-
ficking, and the regulation of cell cycle and apoptosis (Gottwein
et al., 2011; Skalsky et al., 2012).
IL-6 and TNF-a are inflammatory cytokines that are induced
by HCMV early in infection through the activation of nuclear
factor kB (NF-kB) (Kowalik et al., 1993; Yurochko et al., 1997a;
Yurochko et al., 1997b). IL-6 and TNF-a play important roles in
stimulating cellular innate immunity, and HCMV has developed
multiple mechanisms to block the antiviral effects of these in-
flammatory cytokines. These strategies include downregulation
of the TNFR1 from the plasmamembrane, transcriptional repres-
sion of both IL-6 and TNF-a, and posttranscriptional repression
of IL-6 through destabilization of mRNA (Baillie et al., 2003; Jar-
vis et al., 2006; Gealy et al., 2005). IL-6 and TNF-a are released
from the cell through vesicles in the secretory pathway utilizing
a number of endocytic proteins including VAMP3, RAB11A,
and SNAP23 during the process. Both EBV and KSHV encode
miRNAs that regulate vesicular trafficking; thus, miRNA targeting
of key endocytic proteins to limit the release of inflammatoryst & Microbe 15, 363–373, March 12, 2014 ª2014 Elsevier Inc. 363
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Figure 1. HCMV miR-US5-1, miR-US5-2, and miR-UL112-1 Target Components of the Endocytic Compartment
(A) The 30 UTRs of VAMP3 and RAB5C each contain one potential target site for miR-UL112-1. The black boxes represent the open reading frames, white boxes
the UTRs. The position of the target site within the 30 UTR is indicated (gray), as well as the predicted binding between miR-UL112-1 and target sites within each
transcript.
(B) Reporter constructs containing the 30 UTRs of VAMP3 (left panel) or RAB5C (right panel) cloned downstream of renilla were cotransfected into 293 cells with
increasing concentrations of double-stranded miR-UL112-1 mimic or negative control (Neg). At 16 hr posttransfection cell lysates were harvested, and the
relative renilla activity was determined by normalizing to firefly activity and then calculated as percentage of the negative control (% Control).
(C) The predicted miR-UL112-1 target sites (A) were mutated by site-directed mutagenesis to the sequences indicated above the arrows and evaluated in
luciferase assays.
(D) 293 cells were transfected with the miR-UL112-1 concentrations indicated. VAMP3 and RAB5C proteins levels at 48 hr post transfection were evaluated by
western blot analysis. Relative band intensity was determined by dividing the intensity of the band by GAPDH followed by normalization to the untransfected
control.
(E) The 30 UTR reporter constructs were transfected into 293 cells with double-strandedmimics or negative control and relative renilla activity was determine 16 hr
posttransfection by dual-luciferase assay and displayed at percent control (% Control).
(legend continued on next page)
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HCMV miRNAs Restructure the Secretory Compartmentcytokines would provide an attractive mechanism of evading the
innate immune response triggered by IL-6 and TNF-a.
The secretory pathway plays an essential role in HCMV as-
sembly and egress from the cell. Following encapsidation and
partial tegumentation of the HCMV genome in the nucleus, cap-
sids are transported to the virion assembly compartment (VAC)
in the cytoplasm for additional tegumentation and final virion
envelopment. Subsequently, enveloped viral particles egress
from the cell using components of the secretory pathway,
although this process is poorly understood (Alwine, 2012; Das
and Pellett, 2011; Das et al., 2007). The secretory pathway is
composed of the endoplasmic reticulum (ER), Golgi complex,
and trafficking vesicles. These compartments are defined by
their intracellular location, morphology, membrane protein com-
ponents, and lipid composition. Although the site of virion envel-
opment is unknown, multiple secretory organelle markers for the
Golgi, the late and early endosomes, and the endocytic recycling
compartment (ERC) have been associated with the VAC (Buch-
kovich et al., 2009; Cepeda et al., 2010; Krzyzaniak et al.,
2009). Additionally, the morphology of the Golgi appears altered
in HCMV-infected cells with the accumulation of Golgi, ER, and
endosomal proteins with viral glycoproteins and tegument
proteins in the VAC adjacent to the nucleus (Alwine, 2012;
Sanchez et al., 2000a, 2000b). The mechanism through which
HCMV remodels the secretory compartment is unknown but
has been attributed to viral proteins (Alwine, 2012).
In this report we show that multiple HCMV-encoded miRNAs
target several endocytic pathway genes, which serves two
purposes for the virus. The first is to interfere with the trafficking
and release of proinflammatory cytokines providing the virus
with a unique immune evasion strategy. The second is to restruc-
ture components of the secretory pathway, including the Golgi
and endocytic compartment, to form the VAC, leading to
increased efficiency of infectious particle production.
RESULTS
HCMV miRNAs Target Multiple Members of the
Endocytic Pathway
In order to identify cellularmRNA targets of HCMVmiR-UL112-1,
RISC immunoprecipitation followed by DNA microarray analysis
(RIP-CHIP) was performed in HEK293T cells expressing myc-
tagged Ago2 a component of the RISC complex (Grey et al.,
2010; Karginov et al., 2007). Among the top ten mRNAs enriched
in these experiments were vesicle-associated membrane pro-
tein 3 (VAMP3) and RAS-related protein 5C (RAB5C), which are
essential components of the secretory/endocytic pathway (see
Table S1 available online). RAB5C is a small GTPase that func-
tions to ensure the fidelity of vesicle transport and docking to
the acceptor compartment (Zerial and McBride, 2001). VAMP3
is themain component of a protein complex that includes synap-
tosomal-associated proteins that are involved in docking or(F and G) Western blot analyses were performed on 293Ts (F) or NHDFs (G) trans
posttransfection. Relative band intensity was determined by dividing the intensity o
(H) NHDFs were infected with the AD169 wild-type (WT) or the AD169 miR-US5-1
SNAP23 were analyzed 24, 48, and 72 hpi by western blot analysis. Relative ba
followed by normalization with the mock-infected control (MOCK). *p < 0.05 by tw
experimental replicates. Figure 1, related to Figures S1 and S2.
Cell Hofusion of vesicles with the presynaptic or plasma membrane
(Bernstein and Whiteheart, 1999). These mRNAs were also
enriched in RIP-CHIP experiments in human fibroblast cells
infected with HCMV strain TR (Table S2). Analysis of the
VAMP3 and RAB5C sequences indicated that both 30 UTRs
encoded potential target sites for miR-UL112-1 (Figure 1A).
Both of the VAMP3 and RAB5C miR-UL112-1 target sites were
functional, since transfection of HEK293T cells with increasing
concentrations of a miR-UL112-1 double-stranded mimic re-
duced expression of luciferase reporters containing the
VAMP3 and RAB5C 30 UTRs (Figure 1B). In addition, mutation
of the miR-UL112-1 target sites in the luciferase reporters
restored wild-type (WT) activity (Figure 1C). Lastly, both
VAMP3 and RAB5C protein levels were reduced in HEK293T
cells transfected with increasing concentrations of miR-UL112-
1 (Figure 1D). Together these data indicate that a single HCMV
miRNA targets two important members of the secretory/endo-
cytic pathway for reduced expression.
To determine whether other HCMV miRNAs target the
endocytic pathway, we examined whether the 30 UTRs of
VAMP3 andRAB5C, aswell as those of other pathwaymembers,
contained HCMV miRNA seed target sites. We observed that, in
addition to miR-UL112-1 targets sites, VAMP3 and RAB5C
also contained potential target sites for HCMV miR-US5-1 and
that transfection of the miR-US5-1 with luciferase reporters con-
taining the 30 UTRs of these genes also reduced expression (Fig-
ures S1A, S1B, and 1E). Mutation of the miR-US5-1 target sites
in the luciferase reporters restored WT activity (Figures S1A and
S1B). Interestingly, both VAMP3 and RAB5C were coordinately
downregulated by miRs UL112-1 and US5-1 when cotrans-
fected into HEK293Ts or NHDFs (Figures 1F and 1G).
RAS-related protein 11A (RAB11A) and synaptosomal-
associated protein 23 (SNAP23) are also members of the secre-
tory pathway, while the cell division control protein 42 (CDC42) is
critical for actin nucleation and retrograde transport of recycling
endosomes within the secretory pathway. Examination of the 30
UTRs of these genes revealed that each contained potential
seed target sites for one or more HCMV miRNAs (Figures
S1C–S1E). These observations were confirmed using reporter
assays combined with site-directed mutagenesis to confirm
the target sites and indicated that miR-UL112-1 and miR-US5-
1 downregulated expression of the RAB11A and SNAP23, while
miR-US5-2 reduced expression of the SNAP23 and CDC42 (Fig-
ures 1E and S1C–S1E). Similar to VAMP3 and RAB5C, cotrans-
fection of the HCMV miRNAs that were predicted to target
RAB11A or SNAP23 cooperatively downregulated protein
expression (Figures 1F and 1G). Transfection of miR-US5-2
alone reduced CDC42 protein expression (Figures 1F and 1G).
These observations indicate that not only are the HCMVmiRNAs
cooperatively targeting several members of a single cellular
pathway but that they also act together to downregulate single
genes within the pathway.fected with the double-stranded miRNA mimics or negative control (Neg) 48 hr
f the band byGAPDH followed by normalization to the neg-transfected control.
, -US5-2, -UL112-1 mutant virus (Mut), and the levels of RAB5C, RAB11A, and
nd intensity was determined by dividing the intensity of the band by GAPDH
o-tailed Student’s t test. Data represent the mean ± SD of a minimum of three
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Figure 2. HCMV-Encoded miRNAs Down-
regulate VAMP3, RAB5C, RAB11A, and
SNAP23 Protein Levels, Limiting the
Release of Proinflammatory Cytokines
TNF-a and IL-6
For each panel, one representative experiment is
shown of at least three performed.
(A) (Left panels) TPA-treated THP-1 cells trans-
fected with a negative control siRNA were treated
with LPS or mock treated to induce production
and release of TNF-a and IL-6. Supernatants were
collected 8 hr posttreatment and analyzed for
TNF-a and IL-6 release by ELISA. (Right panels)
TPA-treated THP-1 cells were transfected with a
combination of HCMVmiRNAs that were shown to
target components involved in cytokine release
(miRNAs), a combination of siRNAs against those
same transcripts (siRNAs), or a nontargeting
negative control siRNA (Neg) (final concentration
of RNA combined was 50 nM). At 72 hr post-
transfection, cells were treated with LPS to induce
production and release of TNF-a and IL-6. Su-
pernatants were collected 8 hr posttreatment and
analyzed for TNF-a and IL-6 release by ELISA.
(B) Western blot analysis on TPA-treated THP-1
cells in (A) (right panel) using the indicated anti-
bodies.
(C) NHDFs were infected with either the AD169
wild-type virus (WT) or the AD169 miR-US5-1,
-US5-2, -UL112-1 triple mutant virus (Mut), and
the level of IL-6 present in the supernatant 24, 48,
and 72 hpi was determined by ELISA.
(D) NHDFswere transfectedwith HCMVmiRNAs (miRs UL112-1, US5-1, and US5-2), siRNAs (VAMP3, RAB5C, RAB11A, and SNAP23), or negative control siRNA
(Neg) (final concentration of RNA combined was 30 nM) and at 48 hpt were infected with the WT or Mut virus. Supernatants were collected at 24 hr intervals and
tested for IL-6 release; shown is 48 hpi.
(E) Western blot analysis on uninfected NHDFs in (D) using the indicated antibodies. Data are represented as mean ± SD.
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HCMV miRNAs Restructure the Secretory CompartmentNext we generated a miR-UL112-1, miR-US5-1, and miR-
US5-2 AD169 mutant virus to determine if the HCMV miRNAs
downregulate expression of endocytic proteins during viral
infection. miR-UL112-1 is located directly antisense to the
UL114 uracil DNA glycosylase (UDG) gene. To inactivate
miR-UL112-1 function without affecting UDG, seven silent point
mutations were introduced in UDG that disrupted the secondary
structure of the miRNA (Figures S2A and S2B). Analysis of the
mutant demonstrated WT levels of expression of UDG, lack of
miR-UL112-1 expression, and WT viral growth kinetics (Figures
S3A–S3C). To inactivate expression of miR-US5-1 and miR-
US5-2 in the miR-UL112-1 mutant, a 190 nucleotide deletion
was made in the noncoding region between US6 and US7
as previously described (Figure S2C; Tirabassi et al., 2011).
HCMV with mutation of miR-US5-1 and miR-US5-2 alone as
confirmed by stem-loop RT-PCR for miRNAs did not exhibit
altered viral growth in cells (Figures S3D and S3E). Sequence
analysis of the HCMV miRNA triple mutant virus indicated that
the only differences between the mutant and WT virus were
the mutations introduced into the miRNAs, and real-time
PCR confirmed that miR-UL112-1, miR-US5-1, and miR-US5-2
were no longer expressed during infection (Figure S4A). Western
blot analysis of HCMV-infected NHDFs revealed an increase in
expression of RAB5C, RAB11A, and SNAP23 in cells infected
with the HCMV miRNA triple mutant in comparison to cells
infected with the WT virus (Figure 1H). The increase in protein366 Cell Host & Microbe 15, 363–373, March 12, 2014 ª2014 Elsevieexpression correlates with lack of HCMV miRNA expression
and together with the above results indicates that these proteins
are targets of miR-UL112-1, miR-US5-1, and miR-US5-2.
HCMV miRNA Targeting of the Secretory/Endocytic
Pathway Limits the Release of TNF-a and IL-6
Since VAMP3, RAB5C, RAB11A, and SNAP23 play a critical role
in the trafficking and release of TNF-a and IL-6 through the
secretory pathway, we examined the effect of the HCMV
miRNAs that target the endocytic pathway on cytokine release
(Murray et al., 2005; Stow et al., 2006). THP-1 cells were used
in these studies, since neither lipopolysaccharide (LPS) nor
HCMV infection induces significant production or release of
TNF-a in fibroblasts. In these experiments THP-1 cells were
transfected with miR-UL112-1, miR-US5-1, and miR-US5-2 or
siRNAs that target VAMP3, RAB5C, RAB11A, and SNAP23 for
72 hr followed by treatment with or without LPS. The levels of
TNF-a and IL-6 in the supernatants for each were assayed 8 hr
post-LPS treatment. Transfection of cells with either the HCMV
miRNAs or siRNAs reduced secretion of TNF-a by 8-fold and
IL-6 by approximately 2-fold (Figure 2A). Western analysis of
transfected cells for SNAP23, RAB5C, and RAB11A indicated
a 3- to 5-fold reduction of protein (Figure 2B). Subsequently,
we examined the ability of the HCMV miRNA triple mutant to
induce secretion of IL-6 in virus-infected HF cells. As shown in
Figure 2C, mutation of the HCMV miRNAs increased cellularr Inc.
Figure 3. The HCMV miRNAs Facilitate
Formation of the Viral Assembly Compart-
ment
(A) NHDFs were infected with either the AD169
wild-type (WT) or the AD169 miR-US5-1, -US5-2,
-UL112-1 triple mutant virus (Mut) or mock in-
fected (Mock) and analyzed by immunofluores-
cence with the markers indicated as described in
the Experimental Procedures.
(B–E) HeLa cells were transfected with a combi-
nation of HCMVmiRs US5-1, US5-2, and UL112-1
(B); combinations of pathway-specific siRNAs
SNAP23, RAB5C, RAB11A, and CDC42 (C);
SNAP23, RAB5C, and RAB11A (D); or non-
targeting negative control siRNA (E), and the Golgi
complex was evaluated by immunofluorescence
4 days posttransfection for the cis-Golgi marker
GM130 in red and the trans-Golgi marker Gol-
gin245 in green as described in the Experimental
Procedures. This figure is related to Figure S5.
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HCMV miRNAs Restructure the Secretory Compartmentsecretion of IL-6 by 6- to 10-fold in comparison to WT infection,
indicating that the viral miRNAs significantly inhibit cellular
release of the inflammatory cytokine, possibly through altered
function of the secretory pathway. The increased secretion of
IL-6 induced by the HCMV triple miRNA mutant was reduced
to WT levels by either transfection of miR-UL112-1, miR-US5-
1, and US5-2 mimics or combinations of siRNAs targeting
VAMP3, RAB5C, RAB11A, and SNAP23 (Figure 2D). Western
analysis of transfected cells confirmed specific knockdown of
these cellular proteins (Figure 2E). These observations indicate
that HCMV has developed a unique mechanism to prevent cyto-
kine release regardless of the virus-induced innate immune acti-
vation events triggered in the cell.Cell Host & Microbe 15, 363–37HCMV miRNA Targeting of the
Secretory/Endocytic Pathway
Mediates Formation of the Virion
Assembly Compartment
Formation of the VAC occurs during the
late phase of HCMV infection when
HCMV miRNAs are at the highest
concentrations in the cell (Grey et al.,
2005). Since miR-UL112-1, miR-US5-1,
and miR-US5-2 target genes involved
in vesicular transport and membrane
fusion, we examined cells infected with
the HCMV triple miRNA mutant to deter-
mine if viral protein localization in the
VAC was altered during infection. Exami-
nation of HCMV WT infected cells re-
vealed the characteristic accumulation
of the viral glycoprotein gM in the VAC
adjacent to the nucleus that costained
with the Golgi marker TGN46 (Figure 3A).
However, the morphology of the ER was
unaltered, as determined by staining
with an antibody to calreticulin (Fig-
ure S5). In contrast, infection of NHDFs
with the HCMV miRNA triple mutantresulted in the disruption of the VAC into discrete structures
staining with TGN46 and HCMV gM throughout the cell. In order
to determine whether the HCMV miRNAs were sufficient to alter
the morphology of the Golgi, cells were transfected with
miR-UL112-1, miR-US5-1, and US5-2 mimics or combinations
of siRNAs targeting RAB5C, RAB11A, SNAP23, and CDC42.
As shown in Figures 3B–3D, transfection of either the HCMV
miRNAs or the pool of siRNAs disrupted the normal morphology
of the Golgi ribbons and in some cells resulted in the formation of
spherically shaped juxtanuclear structures that were similar in
the morphology of the Golgi during WT HCMV infection. This
phenotype was in sharp contrast to the normal positioning and
morphology of the Golgi in control-transfected cells (Figure 3E).3, March 12, 2014 ª2014 Elsevier Inc. 367
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Figure 4. Mutation of the HCMV miRNAs
Results in Reduced Virus Yield and Small
Plaque Phenotype
(A) NHDFs were infected with the AD169 wild-type
virus (WT-black diamonds) or the AD169 miR-
US5-1, -US5-2, -UL112-1 mutant virus (Mut-gray
squares) (moi = 3, single step; moi = 0.05, multi-
step), and cell-associated and supernatant virus
were harvested at the dpi indicated. Titers were
determined by plaque assay.
(B) Plaque phenotype of the WT and Mut virus
72 hpi on NHDFs. White bar, 0.1 mm.
(C) Relative plaque size of the WT-black bar
compared with the Mut-gray bar. Mean area was
determined 72 hpi on NHDFs and normalized to
WT. *p < 0.05 by two-tailed Student’s t test. Data
are represented as mean ± SD. This figure is
related to Figures S2–S4.
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and RAB5C also resulted in altered morphology of the Golgi
(Figure 3D).
Analysis of the growth kinetics of the HCMV miRNA triple
mutant revealeda2-loggrowthdefect inNHDFsandsmall plaque
phenotype without noticeable defects in immediate-early, early,
and late gene expression; viral genome replication; or incorpora-
tion of major envelope or late tegument proteins into the virion
(Figures 4A–4C and S4B–S4E). This reduction in viral production
by the HCMV mutant may be due to inefficient and/or aberrant
assembly of virus secondary to the disruption of the VAC. There-
fore theplaque-formingunit (PFU) togenomecopynumber (GCN)
ratiowas analyzed forWTandmiRNA triplemutant virus obtained368 Cell Host & Microbe 15, 363–373, March 12, 2014 ª2014 Elsevier Inc.from infected cell supernatants. Com-
parison of WT and miRNA mutant virus
secreted into the supernatant revealed a
400-fold and 100-fold increase in the pro-
duction of noninfectious particles for the
mutant virus at 72 and 96 hr postinfection
(Table 1). A 5-fold increase in PFU:GCN
ratio was detected in cells infected with
the HCMV miRNA triple mutant virus that
were transfected with siRNAs targeting
RAB5C, RAB11A, SNAP23, and CDC42
(Table 2). These results indicate that
HCMVmiRNA targeting of endocytic pro-
teins to restructure the Golgi to form the
VAC is essential for efficient production
of infectious virus.
HCMV miRNA Targeting of the
Secretory/Endocytic Pathway
Results in Accumulation of
Transferrin in the Endocytic
Recycling Compartment
Previous studies of the origins of the VAC
indicated that virion glycoproteins accu-
mulated in a membranous compartment
that could be labeled with markers of
the ERC (Krzyzaniak et al., 2009). In thisearlier study, we demonstrated that accumulation of the major
envelope glycoprotein of HCMV, gM, was dependent on inter-
action of this protein with Rab11 effector protein, Fip4, and
that these proteins along with endocytosed transferrin accumu-
late in the ERC (Krzyzaniak et al., 2009). The targeting of several
components of the endocytic pathway by HCMVmiRNAs raised
the possibility that these miRNAs could impact either endocy-
tosis or endocytic recycling in virus-infected cells. We explored
this possibility by utilizing fluorochrome-conjugated transferrin
in an assay of endocytosis and recycling of endocytosed trans-
ferrin in cells infected with the WT virus expressing the miRNAs
and the viral miRNA mutant. After depletion of endogenous
transferrin, fluorochrome-labeled transferrin was allowed to
Table 1. Mutation of the HCMV miRNAs Results in Altered Virion Fitness
Supernatant Virus
Genome Copy/mL PFU/mL PFU:Genome Copy
72 hpi 96 hpi 72 hpi 96 hpi 72 hpi 96 hpi
WT 630,538 1,683,477 65,000 110,000 1:10 1:15
Mut 221,094 653,125 5 60 1:44,219 1:10,885
NHDFswere infected with either the AD169 wild-type (WT) or the AD169miR-US5-1, -US5-2, -UL112-1 triple mutant virus (Mut) (moi = 3, 2 hr) followed
by acid wash to remove extracellular virus. At 72 and 96 hpi, supernatant virus was harvested and the PFU/genome copy was determined by virus
titration on NHDFs and real-time PCR.
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unlabeled transferrin to analyze the recycling of this protein. As
can be seen in Figure 5, cells infected with WT and mutant virus
bound and internalized transferrin similarly. Interestingly, after a
60 min chase period, similar amounts of transferrin were present
in a juxtanuclear site of cells infected with the WT virus, whereas
minimal to undetectable amounts of transferrin were present in
cells infected with the mutant virus and in uninfected adjacent
cells (Figure 5). These findings support the hypothesis that the
miRNA targeting the components of the secretory/endocytic
pathway alters the kinetics of transferrin recycling, favoring
accumulation of the protein in the ERC. This result is consistent
with previous observations demonstrating the localization of
transferrin in the VAC of WT HCMV-infected cells (Krzyzaniak
et al., 2009).
DISCUSSION
In summary, our studies indicate that multiple members of
the endocytic pathway, including VAMP3, RAB5C, RAB11A,
SNAP23, and CDC42, are targeted by the HCMV miRs
UL112-1, US5-1, and US5-2. Mutation of these miRNAs resulted
in significant consequences for virus infectivity, including
increased release of proinflammatory cytokines, and major
impacts on viral phenotypes including malformation of the
VAC, reduction of supernatant virus, and increased production
of defective particles. We show that the targeting of the endo-
cytic pathway genes by multiple HCMV-encoded miRNAs
serves at least two purposes for the virus. The first is to interfere
with the trafficking and release of proinflammatory cytokines
providing the virus with a unique immune evasion strategy, while
the second is to restructure components of the secretory
pathway, including the Golgi and endocytic compartment, to
form the VAC, leading to increased production of infectious
particles.
Both IL-6 and TNF-a are proinflammatory cytokines that play
important roles in both innate and acquired immunity. IL-6 is
the predominant inducer of the acute-phase response, while
TNF-a plays a key role in controlling viral infections, exemplified
by experiments using TNF-a inhibitors that result in both
increased viral replication and pathogenicity in vivo (Yerkovich
et al., 1997). The importance of these cytokines in controlling
viral infections is underscored by the fact that multiple viruses,
including HCMV, have evolved strategies to interfere with IL-6
and TNF-a production and release or that mitigate their effects.
These strategies include downregulating cytokine receptors,
interfering with recruitment of adaptor proteins and subsequent
downstream signaling events, and neutralizing newly released
cytokines (Rahman andMcFadden, 2006). Additionally, viral pro-Cell Hoteins have been reported to interfere with release of cytokines
from infected cells. For example, the HIV-encoded protein nef
interferes with delivery of TNF-a to the plasma membrane in
HIV-infected macrophages by preventing recruitment of AP1
(Mazzolini et al., 2010). By reducing or preventing cytokine
release from infected cells, HCMV creates an environment
more favorable for virus replication and spread. Unlike previously
identified mechanisms which rely on the expression of exo-
genous proteins that likely elicit an immune response, HCMV
accomplishes this using multiple viral miRNAs that are not
immunogenic.
Over the past two decades a significant amount of effort has
been devoted to characterizing the formation and composition
of the HCMV VAC. The final stages of HCMV particle formation
occur in the VAC, where final tegumentation and acquisition of
envelope proteins occurs followed by egress from the cell using
the secretory machinery. The mature VAC is most readily de-
tected late during the virus replication cycle when HCMVmiRNA
expression peaks. VAC formation also occurs at an interval when
altered distribution of secretory pathway proteins is observed in
infected cells. Analysis of the VAC for components of the secre-
tory pathway indicated the presence of markers for the ER-to-
Golgi intermediate compartment, trans-Golgi network (TGN),
and early and recycling endosomes (Das and Pellett, 2007,
2011; Sanchez et al., 2000a, 2000b). While HCMV proteins are
considered to regulate the formation of the VAC, the obser-
vations in this study indicate that viral miRNAs that downregulate
key components of the secretory pathway also contribute to the
remodeling of the secretory pathway during infection. The reor-
ganization of the secretory pathway that facilitates VAC forma-
tion may be related to the membrane remodeling that occurs
during induction of either cell death or cytokinesis (Grant and
Donaldson, 2009; Landry et al., 2009). In each case, a significant
amount of the plasmamembrane is ingested into the cell through
the endosomal compartment by temporarily blocking endoso-
mal recycling while allowing endocytosis to proceed (Grant
and Donaldson, 2009; Landry et al., 2009; Boucrot and Kirch-
hausen, 2007). This event leads to loss of plasma membrane
area and accumulation of membrane in the endosomal system.
Endosomal recycling depends upon many proteins including
RAB5, RAB7, RAB11, CDC42, and actin (Grant and Donaldson,
2009). Interfering with these proteins can inhibit recycling as well
as alter position of the endosomal recycling compartment within
the cell (Grant and Donaldson, 2009; Tomas et al., 2010; Hehnly
et al., 2010). Our findings that demonstrate an inhibition of
transferrin recycling in WT HCMV but not in mutant HCMV-
infected cells are consistent with these previous studies and
suggest that formation of the VACmay require inhibition of anter-
ograde trafficking in more distal compartments of the secretoryst & Microbe 15, 363–373, March 12, 2014 ª2014 Elsevier Inc. 369
Table 2. Transfection with siRNAs against Endocytic Compartment Genes Restores the PFU:GCN Ratio
Transfection Group
Genome Copy/mL PFU/mL PFU:Genome Copy
Neg
RAB5C, RAB11A,
SNAP23, CDC42 Neg
RAB5C, RAB11A,
SNAP23, CDC42 Neg
RAB5C, RAB11A,
SNAP23, CDC42
72 hpi WT 1,707,942 1,099,182 165,000 350,000 1:10 1:3
Mut 161,927 222,080 250 1,800 1:648 1:123
96 hpi WT 755,499 518,324 650,000 550,000 1:1 1:1
Mut 816,361 1,337,559 1,550 11,100 1:527 1:121
NHDFs were transfected with siRNAs targeting RAB5C, RAB11A, SNAP23, and CDC42 or negative control and were then infected with either the
AD169 wild-type (WT) or the AD169 miR-US5-1, -US5-2, -UL112-1 triple mutant virus (Mut) (moi = 3, 2 hr). At 72 and 96 hpi, supernatant virus was
harvested and the PFU/genome copy determined by virus titration on NHDFs and real-time PCR.
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the accumulation of viral proteins in proximity of the ERC. Finally,
it is noteworthy that both decreased secretion of TNF-a and IL-6
and inhibition of transferrin recycling represent functional pheno-
types of cells infected with viruses expressing these viral
miRNAs, an observation that further supports the role of these
miRNAs in remodeling the secretory pathway to optimize virus
assembly and replication.
The ultimate effect of HCMVmiRNA-mediated reduction of the
RAB proteins, SNAP23, and CDC42 is the condensation and
reorganization of the Golgi, TGN, and endosomes into the VAC
adjacent to the nucleus. Transfection of a pool of either the
HCMV miRNAs or siRNAs targeting the endocytic proteins was
sufficient to disrupt the morphology of the Golgi and to generate
structures that resemble the VAC. These results, in combination
with the observation that infection of cells with the HCMVmiRNA
mutant results in lack of VAC formation and normal formation of
Golgi stacks in the cell, indicate that the viral miRNAs are respon-
sible for VAC formation. Lastly, the observation that mutation of
the miRNAs in the virus resulted in up to a 3-log increase in
noninfectious particles is consistent with the role of the VAC in
the concentration of viral proteins into a single structure within
the secretory machinery, which in turn can lead to more efficient
infectious particle formation (Sanchez et al., 2000a, 2000b). An
important question raised by these results is how particles that
mature in the VAC egress from the cell with the loss of the secre-
tory pathway machinery. Do recycling endosomal vesicles with
infectious virion cargo traffic between the VAC and the plasma
membrane for particle release? And if so, how does this occur
with the loss of docking molecules? The ability to genetically
regulate formation of the VAC will provide us with a tool to
dissect these and other mechanisms involved in viral assembly
and egress from the cell.
Rescuing the HCMV triple mutant with the viral miRNAs is
complicated by the fact that each individual miRNA has the
potential to target greater than 100 genes. Therefore using the
viral miRNAs mutated in the virus to rescue the HCMV mutant
would not conclusively demonstrate that the downregulation of
the secretory genes by the miRNAs is solely responsible for
the phenotype. In addition, since miR-UL112-1 also targets the
viral transcriptional activator IE72 and UL112/113, which are
involved in viral DNA replication, as well as UL120/121 that has
an unknown function (Grey et al., 2007), using this miRNA to
rescue the mutant viral phenotype would be complicated by370 Cell Host & Microbe 15, 363–373, March 12, 2014 ª2014 Elseviethe miRNA off-target effects. An additional complicating factor
is that miRs US5-1 and US5-2 target US7, which is an HCMV
gene with unknown function. Therefore, to rule out off-target
effects of the HCMV miRNAs, we utilized siRNAs targeting
RAB5C, RAB11A, SNAP23, and CDC42 to rescue the HCMV
miRNA triple mutant. Using this approach we were able to re-
constitute WT HCMV VAC formation as well as reduce pro-
duction of noninfectious particles. Similarly, siRNAs directed
against the secretory genes also rescued the ability of the
HCMV triple miRNA mutant to reduce the release of proinflam-
matory cytokines. Importantly, we observed that transfection
of the viral miRNAs or siRNAs to the secretory gene targets is
sufficient to form the VAC or decrease secretion of proinflamma-
tory cytokines in the absence of virus infection, indicating that
the phenotype is solely dependent on the viral miRNAs targeting
the secretory pathway genes.
These results indicate that multiple viral miRNAs coordinately
target multiple genes in a single cellular pathway that are an
essential part of the viral replication process and provide a
mechanistic explanation for formation of the VAC. These results
also indicate that viral miRNAs are a critical part of the virus lytic
life cycle and that the full extent of viral mutant phenotypes can
only be observed following mutation of multiple miRNA in the
virus that coordinately regulate pathways. The future identifica-
tion of cellular pathways targeted by HCMV miRNAs will allow
the targeted mutation of these regulatory RNAs to explore the
importance of these pathways in viral replication and latency.EXPERIMENTAL PROCEDURES
Cells and Viruses
HEK293T cells (293T), normal human dermal fibroblasts (NHDFs), and HeLa
cells were grown in Dulbecco’s modified Eagle’s medium supplemented
with 10% heat-inactivated fetal bovine serum (FBS), 1.0 unit/mL penicillin,
1.0 ug/mL streptomycin, and 292 ng/mL L-glutamine (PSG) (Life Technolo-
gies). HEK293T cells that stably express a c-myc-tagged Argonaute 2 protein
(A2) were grown in the medium above supplemented with 300 ug/mL genta-
micin (Invitrogen) (Karginov et al., 2007). A human monocyte-derived cell line
(THP-1) was grown in RPMI-1640 supplemented with 10% heat-inactivated
FBS and PSG. Monocytic differentiation was induced by adding 10 ng/mL
12-O-tetradecanoylphorbol-13-acetate (TPA) to the medium. Stocks of
HCMV were grown and titered in NHDFs using standard techniques. For viral
growth curves, NHDFs were infected in duplicate at an moi of 3 for single step
or moi 0.05 for multistep for 2 hr. Cells were then washed extensively, and both
cell-associated and supernatant viruseswere harvested atmultiple time points
postinfection. Titers were determined by plaque assay on NHDFs. In somer Inc.
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Chase T=0 Chase T=60 Figure 5. HCMV miRNAs Inhibit Transferrin
Recycling
NHDFs were infected with the AD169 wild-type
(WT) or the AD169 miR-US5-1, -US5-2, -UL112-1
mutant virus (Mut) (moi = 0.8). At 72 hpi NHDFs
were labeled with transferrin conjugated with
Alexa Fluor 488 for 30 min. Following a 0 and
60 min chase in unlabeled media containing 10%
FBS, the cells were imaged for transferrin (green),
the early endosome marker EEA1 (blue), HCMV
pp65 (red), and DAPI. While bar, 10 mM; asterisk
indicates infected cells. White arrow indicates WT
infected cell with mature VAC.
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HCMV miRNAs Restructure the Secretory Compartmentcases, average plaque size was determined 72 hpi on NHDFs and normalized
to WT. PFU/GCN was determined by isolating supernatant virus at 72 and
96 hpi, followed by virus titration on NHDFs and real-time PCR to detect
GCN. In some cases, NHDFs were transfected with pools of miRNAs,
siRNAs, or negative controls 48 hr prior to infection using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s instructions with the modi-
fication that cells were plated and maintained in DMEM supplemented with
1%FBS for the length of the experiment. For experiments evaluating knock-
down of VAMP3 in 293T cells, a vector containing the VAMP3 full-length
cDNA clone was transfected into cells using Lipofectamine 2000 along with
the small RNAs (OriGene Technologies).
RIP-CHIP
RIP-CHIP was performed as previously described (Grey et al., 2010). Briefly,
A2 cells were transfected with a pSIREN expression plasmid encoding the
HCMV miR-UL112-1 pre-miR hairpin or a negative control using Fugene
according to the manufacturer’s instructions (Roche). At 72 hpt, cell lysates
were harvested, and mRNA associated with the RISC complex was isolated
with anti-c-myc agarose beads (Sigma). RNA was isolated from both total
and immunoprecipitated cellular lysates using Trizol (Invitrogen) and analyzed
for quality using an Agilent Bioanalyzer. mRNA transcript levels were deter-
mined using the Illumina HumanRef-8 platform and analyzed using Gene Sifter
software. To identify cellular mRNA transcripts specifically enriched within
RISC complex containing miR-UL112-1, the enrichment profile in miR-
UL112-1 transfected cells was compared to cells transfected with the negative
control vector such that the enrichment value of any given mRNA transcript =
(IP112/Total112)/(IPNeg/TotNeg) (Grey et al., 2010). mRNA transcripts were then
ranked according to level of enrichment, with the highest enriched transcripts
considered potential targets of miR-UL112-1. Two independent experiments
were performed to increase confidence in the identified targets. Predicted
binding sites between miRNAs and potential targets were determined by look-
ing for seed sequence matches or by using the online software RNAhybrid
(Grey et al., 2010; Tirabassi et al., 2011). For analysis of HCMV miRNA targets
during infection, NHDFswere infectedwith HCMV strain TR (moi = 3). At 72 hpi,
cells were lysed, samples were taken for total RNA, and miRNA in complex
with endogenous Ago2 was immunoprecipitated using an anti-Ago2 antibody
followed by streptavidin bead pull-down. RNA was isolated using Trizol and
analyzed for quality using an Agilent Bioanalyzer and transcript levels deter-
mined on the Illumina HumanRef-8 platform. Microarray data were analyzed
using Gene Sifter software. Enrichment of specific transcripts, through asso-
ciation with miRNP complexes, was determined by dividing the immunopre-Cell Host & Microbe 15, 363–37cipitated levels of transcripts by the total levels.
Transcripts were then ranked according to the
level of enrichment, with the highest enriched
transcripts considered potential targets of HCMV
miRNAs.
Reagents
Double-stranded miRNA mimics for the HCMV-
encoded miRNAs were designed using the pub-
lished miRNA sequences (http://www.mirbase.org) as described previously (Grey et al., 2010; Tirabassi et al., 2011).
VAMP3, RAB5C, RAB11A, SNAP23, CDC42, and negative control siRNAs
were purchased from Ambion (http://www.ambion.com).
Cloning and Site-Directed Mutagenesis
The 30 UTRs of VAMP3, RAB5C, RAB11A, SNAP23, and CDC42 were PCR
amplified from 293T cDNA and cloned downstream of the renilla luciferase
gene in a psiCHECK-2 dual reporter construct (Promega). A PCR-based
site-directed mutagenesis protocol was used to introduce mutations into
potential miRNA binding sites.
Luciferase Assay
293T cells were cotransfected with the 30 UTR dual-luciferase reporter con-
structs and miRNA mimics using Lipofectamine 2000 (Invitrogen) according
to themanufacturer’s instructions. Cells were harvested 16 hr posttransfection
and renilla, and luciferase levels weremeasured using Promega’s dual reporter
assay.
Northern Blot Analysis for miRNAs
NHDFs were infected at moi 3, and total RNA was harvested and subjected
to northern blot analysis using probes specific for predicted viral miRNA
sequences.
RT-PCR Analysis
Total RNA was harvested using Trizol and reverse transcribed using either
random hexamers or specific RT primers for miRNA RT-PCR. Gene specific
primer-probe sets (Taqman, ABI) were then used for real-time amplification.
Western Blot Analysis
Extracts were run on an 8%–12% SDS-PAGE, transferred to Immobilon-P
Transfer Membranes (Milipore Corp.), and visualized with antibodies specific
for VAMP3 (SySy), RAB5C (Sigma), RAB11A (Cell Signaling), SNAP23
(SySy), CDC42 (Sigma), Flag (Sigma), and GAPDH (Abcam).
ELISA
THP-1 cells were seeded at a density of 2.5 3 105 cells/well in 24-well plates
and treated with TPA to induce monocytic differentiation. Twenty-four hours
later, cells were transfected with HCMV miRNAs; siRNAs directed against
VAMP3, RAB5C, RAB11A, and SNAP23; or negative control siRNA using
Lipofectamine 2000. At 72 hpt, cells were treated with LPS to induce TNF-a
and IL-6 secretion. Supernatants were collected 8 hr posttreatment,3, March 12, 2014 ª2014 Elsevier Inc. 371
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HCMV miRNAs Restructure the Secretory Compartmentcentrifuged to remove cell debris, and analyzed for TNF-a and IL-6 by ELISA
according the manufacturer’s instructions (BD OptEIA). In experiments
comparing IL-6 release from WT and AD169 miR-US5-1, -US5-2, -UL112-1
triple mutant virus infected cells, NHDFs were infected at moi 3 as described
above, and IL-6 release was determined by ELISA.Immunofluorescence
Localization of viral and cellular proteins was determined by indirect immuno-
fluorescence. NHDFs grown on 13 mm glass coverslips were infected with the
AD169 WT or AD169 miR-US5-1, -US5-2, -UL112-1 triple mutant virus at moi
0.1. At 6 dpi, coverslips were washed with DPBS and fixed in DPBS containing
4% paraformaldehyde. Cells were permeabilized with 0.1% Triton X-100, and
blocked with 10%–50% normal goat serum (Invitrogen). The coverslips were
then incubated with primary antibody including anti-calreticulin, anti-
golgin245, anti-gm130, anti-TGN46, anti-HCMV IE-1 (mab p63-27), anti-gM
(mab IMP), and anti-gM/gN (mab 14-16A). Cells were then washed and incu-
bated with the appropriate fluorophore-conjugated secondary antibody
(Southern Biotech). In some experiments, HeLa cells were electroporated
with siRNAs using the basic nucleofector kit (Amaxa Bioscience) prior to
immunostaining. In experiments evaluating transferrin internalization and recy-
cling, NHDFs were infected with the WT or Mut virus (moi = 0.8, 72 hr), starved
2 hr in serum-free media, and then labeled with transferrin conjugated with
Alexa Fluor 488 for 30 min at 37C. The coverslips were then washed three
times with cold PBS; placed in complete media for 0, 10, 20, 30, 45, and
60 min chase periods at 37C; and imaged for transferrin, EEA1, DAPI, and
HCMV pp65 (mab 28-19). Fluorescence was visualized using an Olympus
Fluoview 1000 confocal microscope utilizing identical laser and gain settings
for comparative studies.Statistical Analysis
The Student’s t test (Microsoft Excel software) was used to determine p values.
Results were considered significant at a probability (p) < 0.05.SUPPLEMENTAL INFORMATION
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